HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ursula Ravens Selected Research

CGP 20712A

4/2003Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
5/2002Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ursula Ravens Research Topics

Disease

49Atrial Fibrillation
01/2021 - 05/2002
17Heart Failure
01/2021 - 06/2005
7Cardiac Arrhythmias (Arrythmia)
01/2018 - 05/2003
6Stroke (Strokes)
01/2021 - 01/2009
5Fibrosis (Cirrhosis)
01/2021 - 04/2014
5Atrial Remodeling
01/2018 - 05/2003
5Tachycardia (Tachyarrhythmias)
06/2009 - 05/2002
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2018 - 06/2005
4Overactive Urinary Bladder (Overactive Bladder)
04/2010 - 11/2002
3Heart Diseases (Heart Disease)
01/2021 - 08/2009
2Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2012
2Thromboembolism
01/2019 - 01/2009
2Left Ventricular Dysfunction
01/2018 - 06/2017
2Hypertrophy
05/2017 - 05/2003
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2015 - 12/2013
2Ischemia
10/2010 - 03/2010
1Ventricular Fibrillation
01/2019
1Long QT Syndrome
01/2018
1Short Qt Syndrome
01/2018
1Type 2I Limb-Girdle Muscular Dystrophy
01/2018
1Thrombosis (Thrombus)
01/2018
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2018
1Ventricular Tachycardia
01/2018
1Cardiomyopathies (Cardiomyopathy)
01/2017
1Inflammation (Inflammations)
01/2017
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016
1Lower Urinary Tract Symptoms
04/2011
1Acute Coronary Syndrome
12/2009
1Cognitive Dysfunction
12/2009

Drug/Important Bio-Agent (IBA)

11Anti-Arrhythmia AgentsIBA
01/2019 - 04/2007
9Pharmaceutical PreparationsIBA
01/2021 - 11/2002
7Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2008
7Ion Channels (Ion Channel)IBA
01/2021 - 05/2003
6CalciumIBA
01/2019 - 06/2008
5CatecholaminesIBA
01/2018 - 01/2006
4Messenger RNA (mRNA)IBA
01/2021 - 06/2005
4Acetylcholine (Acetylcholine Chloride)FDA Link
03/2018 - 01/2008
4Potassium Channels (Potassium Channel)IBA
01/2018 - 06/2005
4Epinephrine (Adrenaline)FDA LinkGeneric
07/2014 - 05/2002
4PotassiumIBA
10/2010 - 06/2007
3Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2018 - 04/2005
3SodiumIBA
12/2016 - 05/2003
3Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2014 - 01/2006
3Metoprolol (Toprol-XL)FDA LinkGeneric
07/2014 - 01/2006
3Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
04/2011 - 06/2007
3propiverineIBA
04/2010 - 11/2006
3AutoantibodiesIBA
10/2006 - 07/2004
2CollagenIBA
01/2021 - 03/2018
2Cholinergic Agents (Cholinergics)IBA
03/2018 - 07/2004
21-(9-fluorenyl)ethyl chloroformateIBA
06/2017 - 07/2012
2Serotonin (5 Hydroxytryptamine)IBA
01/2016 - 07/2014
2Vitamin KFDA Link
08/2015 - 01/2009
2Adrenergic Receptors (Adrenergic Receptor)IBA
07/2014 - 06/2013
2RolipramIBA
07/2014 - 01/2009
2Carvedilol (Coreg)FDA LinkGeneric
07/2014 - 01/2006
2vernakalantIBA
03/2014 - 04/2013
2AnticoagulantsIBA
11/2013 - 01/2012
2Parasympatholytics (Antispasmodics)IBA
02/2008 - 11/2002
2ICI 118551IBA
04/2003 - 05/2002
2CGP 20712AIBA
04/2003 - 05/2002
1RotenoneIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2021
1NexusIBA
01/2020
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020
1ProteomeIBA
01/2018
1Angiotensin IIIBA
01/2018
1Estradiol (Delestrogen)FDA LinkGeneric
01/2018
1Estrogens (Estrogen)FDA Link
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2018
1Aligeron (AS 2)IBA
01/2018
1Flecainide (Tambocor)FDA LinkGeneric
06/2017
1Brain Natriuretic Peptide (Natrecor)FDA Link
05/2017
1EndotoxinsIBA
01/2017
1SEA 0400IBA
10/2016
1Sodium-Calcium ExchangerIBA
10/2016
1S66913IBA
02/2016
1EnzymesIBA
01/2016
1exodeoxyribonuclease IIBA
01/2016
1cilostamideIBA
07/2014
1Matrix Metalloproteinases (MMPs)IBA
04/2014
1Transforming Growth Factor beta (TGF-beta)IBA
04/2014
1DronedaroneFDA Link
03/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2014
1RanolazineFDA Link
03/2014
1N- (6- (1- (4- fluorophenyl)- 2,2- di(pyridin- 3- yl)ethyl)pyridin- 2- yl)methanesulfonamideIBA
01/2014
1XEN-D0101IBA
05/2013
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2012
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2012
1Dopamine (Intropin)FDA LinkGeneric
01/2012

Therapy/Procedure

17Therapeutics
01/2021 - 08/2006
2Drug Therapy (Chemotherapy)
01/2021 - 01/2020
2Electric Countershock (Cardioversion)
06/2017 - 07/2012
2Cystectomy
01/2015 - 12/2013
2Catheter Ablation
11/2013 - 12/2009
1Operative Surgical Procedures
01/2019
1Electrodes (Electrode)
01/2018
1Contraindications
08/2015
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2011